Analyst Price Targets — PRTC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2022 5:48 pm | Edward Tenthoff | Piper Sandler | $44.00 | $30.50 | TheFly | PureTech Health price target raised to $44 from $37 at Piper Sandler |
| August 9, 2022 4:36 am | — | Leerink Partners | $70.00 | $27.52 | Benzinga | SVB Leerink Maintains Outperform on PureTech Health, Raises Price Target to $70 |
| June 15, 2022 4:19 am | — | Leerink Partners | $66.00 | $19.50 | Benzinga | SVB Leerink Maintains Outperform on PureTech Health, Lowers Price Target to $66 |
| June 14, 2022 1:37 pm | Edward Tenthoff | Piper Sandler | $37.00 | $19.50 | TheFly | PureTech Health price target lowered to $37 from $72 at Piper Sandler |
Latest News for PRTC
BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.
BOSTON--(BUSINESS WIRE)--PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference.
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial...
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial public offering at the top of its target range, putting the clinical-stage neuropsychiatry company on course to raise gross proceeds of $254.9 million. In London, PureTech shareholders saw the share price climb 9.56% to 139.8p.
PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PRTC.
Senate Trading
No Senate trades found for PRTC.
U.S. House Trading
No House trades found for PRTC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.